Director, Ophthalmology, SingHealth
• Speaker, Artificial Intelligence Symposium, 17 Sep 2021
Assoc Prof Daniel Ting is the Director of SingHealth Artificial Intelligence (AI) Programme, Head of AI and Digital Innovation in Singapore Eye Research Institute (SERI), Associate Professor in Ophthalmology with Duke-NUS Medical School Singapore.
Globally, Assoc Prof Ting serves in several AI executive committees (American Academy of Ophthalmology, USA and STARD, UK) and AI editorial boards (Nature Digital Medicine, Frontiers in Medicine and Ophthalmology). In 2017, as the US-ASEAN Fulbright Scholar, he visited the Johns Hopkins University to deepen the AI collaboration between US and the ASEAN regions.
He is the regular invited chair, moderator and invited speaker in scientific conferences and prestigious universities, for example the Trinity College at Cambridge, Oxford University, Johns Hopkins University, etc.
He has published more than 180 peer-reviewed papers in highly prestigious journals such as JAMA, NEJM, Nature Medicine and also has three patents in the deep learning domains. In the recent ExpertScape ranking, he was ranked the world’s most influential deep learning researcher across all domains in healthcare for the past 10 years (2010-2021).
For the accomplishment, Assoc Prof Ting was recognised by many top-tiered international AI and ophthalmology societies and won many prestigious scientific awards, including the MICCAI OMIA Prestigious Achievement Award (2020), ARVO Bert Glaser Award for Innovative Research in Retina (2020), USA Macula Society Evangelos Gragoudas Award (2019).
With the advancement of AI technology, Assoc Prof Ting hopes to harness the power of digital technology, including big data, deep learning and blockchain, to improve patients’ outcome, experience, reduce health economic burden and more importantly, narrow the gap of inequality of health care access, standard and delivery globally.